top of page
Who we are
We are an Austrian startup developing personalized cancer vaccines.
Currently, we are preparing for our first clinical trial.
Technology
We employ Cutting-Edge Artificial Intelligence models to diagnose the optimal antigens and use
them design the Individualized Vaccines. Our model mimics the natural process of T-cell
response and is fueled by Real World Evidence data to accomplish a constant evolution in
performance.
Vaccine platform
We developed the first individualized vaccine platform with pure peptides comprised of
interchangeable antigens.
Our Team
Our Supporters
Gefördert durch Preseed – Deep Tech des BMDW bzw. des BMK abgewickelt durch die aws.
bottom of page